Obese adolescents with polycystic ovarian syndrome have elevated cardiovascular disease risk markers
Sonali S. Patel(The University of Texas Southwestern Medical Center), Melanie Cree‐Green(University of Colorado Boulder), Annie Ferland(University of Colorado Anschutz Medical Campus), Martina King(University of Colorado Anschutz Medical Campus), John E. Hokanson(University of Colorado Anschutz Medical Campus), Kerrie L. Moreau(VA Eastern Colorado Health Care System), Jennifer L. Dorosz(University of Colorado Anschutz Medical Campus), Uyen Truong, Robert H. Eckel(University of Colorado Anschutz Medical Campus), David M. Maahs(Stanford University), Kristen J. Nadeau(Children's Hospital Colorado), Hong Wang(Colorado School of Public Health), Gregory L. Kinney(Colorado School of Public Health)
Cited by 63
Related Papers
International Consensus on Use of Continuous Glucose Monitoring
|Diabetes Care|2017|2k
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
|Circulation|2023|1.7k
Definition and diagnostic criteria of clinical obesity
|The Lancet Diabetes & Endocrinology|2025|1.5k
Genetic Epidemiology of COPD (COPDGene) Study Design
|COPD Journal of Chronic Obstructive Pulmonary Disease|2010|1.3k
2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk
|Journal of the American College of Cardiology|2013|1.2k